Oxaliplatin-Europe Market Status and Trend Report 2015-2026
REPORT SUMMARY
Oxaliplatin-Europe Market Status and Trend Report 2015-2026 offers a comprehensive analysis on Oxaliplatin industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Oxaliplatin 2015-2019, and development forecast 2020-2026
Main market players of Oxaliplatin in Europe, with company and product introduction, position in the Oxaliplatin market
Market status and development trend of Oxaliplatin by types and applications
Cost and profit status of Oxaliplatin, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Oxaliplatin market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Oxaliplatin industry.
The report segments the Europe Oxaliplatin market as:
Europe Oxaliplatin Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2015-2026):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Oxaliplatin Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2015-2026):
Mannitol
Glucose Solution
Lactose Solution
Other
Europe Oxaliplatin Market: Application Segment Analysis (Consumption Volume and Market Share 2015-2026; Downstream Customers and Market Analysis)
Colorectal Cancer
Stomach Cancer
Ovarian Cancer
Other
Europe Oxaliplatin Market: Players Segment Analysis (Company and Product introduction, Oxaliplatin Sales Volume, Revenue, Price and Gross Margin):
Sanofi-Aventis
Mylan
Sun Pharmaceutical
Yakult honsha
Hospira
Dr Reddy's laboratories
Nanjing Pharmaceutical Factory
Fresenius Kabi
Teva
Jiangsu Hengrui Medicine
Luoxin
Hainan Jinrui Pharmaceutical
Jiangsu Aosaikang Pharmaceutical
Chiatai Tianqing
Halfsky Pharmacy
Lunan Pharmaceutical
Qilu Pharmaceutical
Jari Pharmaceutical
YRPG
Hisun Pharmaceutical
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Oxaliplatin-Europe Market Status and Trend Report 2015-2026 offers a comprehensive analysis on Oxaliplatin industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Oxaliplatin 2015-2019, and development forecast 2020-2026
Main market players of Oxaliplatin in Europe, with company and product introduction, position in the Oxaliplatin market
Market status and development trend of Oxaliplatin by types and applications
Cost and profit status of Oxaliplatin, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Oxaliplatin market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Oxaliplatin industry.
The report segments the Europe Oxaliplatin market as:
Europe Oxaliplatin Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2015-2026):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Oxaliplatin Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2015-2026):
Mannitol
Glucose Solution
Lactose Solution
Other
Europe Oxaliplatin Market: Application Segment Analysis (Consumption Volume and Market Share 2015-2026; Downstream Customers and Market Analysis)
Colorectal Cancer
Stomach Cancer
Ovarian Cancer
Other
Europe Oxaliplatin Market: Players Segment Analysis (Company and Product introduction, Oxaliplatin Sales Volume, Revenue, Price and Gross Margin):
Sanofi-Aventis
Mylan
Sun Pharmaceutical
Yakult honsha
Hospira
Dr Reddy's laboratories
Nanjing Pharmaceutical Factory
Fresenius Kabi
Teva
Jiangsu Hengrui Medicine
Luoxin
Hainan Jinrui Pharmaceutical
Jiangsu Aosaikang Pharmaceutical
Chiatai Tianqing
Halfsky Pharmacy
Lunan Pharmaceutical
Qilu Pharmaceutical
Jari Pharmaceutical
YRPG
Hisun Pharmaceutical
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF OXALIPLATIN
1.1 Definition of Oxaliplatin in This Report
1.2 Commercial Types of Oxaliplatin
1.2.1 Mannitol
1.2.2 Glucose Solution
1.2.3 Lactose Solution
1.2.4 Other
1.3 Downstream Application of Oxaliplatin
1.3.1 Colorectal Cancer
1.3.2 Stomach Cancer
1.3.3 Ovarian Cancer
1.3.4 Other
1.4 Development History of Oxaliplatin
1.5 Market Status and Trend of Oxaliplatin 2015-2026
1.5.1 Europe Oxaliplatin Market Status and Trend 2015-2026
1.5.2 Regional Oxaliplatin Market Status and Trend 2015-2026
CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Oxaliplatin in Europe 2015-2019
2.2 Consumption Market of Oxaliplatin in Europe by Regions
2.2.1 Consumption Volume of Oxaliplatin in Europe by Regions
2.2.2 Revenue of Oxaliplatin in Europe by Regions
2.3 Market Analysis of Oxaliplatin in Europe by Regions
2.3.1 Market Analysis of Oxaliplatin in Germany 2015-2019
2.3.2 Market Analysis of Oxaliplatin in United Kingdom 2015-2019
2.3.3 Market Analysis of Oxaliplatin in France 2015-2019
2.3.4 Market Analysis of Oxaliplatin in Italy 2015-2019
2.3.5 Market Analysis of Oxaliplatin in Spain 2015-2019
2.3.6 Market Analysis of Oxaliplatin in Benelux 2015-2019
2.3.7 Market Analysis of Oxaliplatin in Russia 2015-2019
2.4 Market Development Forecast of Oxaliplatin in Europe 2020-2026
2.4.1 Market Development Forecast of Oxaliplatin in Europe 2020-2026
2.4.2 Market Development Forecast of Oxaliplatin by Regions 2020-2026
CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Europe Market Status by Types
3.1.1 Consumption Volume of Oxaliplatin in Europe by Types
3.1.2 Revenue of Oxaliplatin in Europe by Types
3.2 Europe Market Status by Types in Major Countries
3.2.1 Market Status by Types in Germany
3.2.2 Market Status by Types in United Kingdom
3.2.3 Market Status by Types in France
3.2.4 Market Status by Types in Italy
3.2.5 Market Status by Types in Spain
3.2.6 Market Status by Types in Benelux
3.2.7 Market Status by Types in Russia
3.3 Market Forecast of Oxaliplatin in Europe by Types
CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Oxaliplatin in Europe by Downstream Industry
4.2 Demand Volume of Oxaliplatin by Downstream Industry in Major Countries
4.2.1 Demand Volume of Oxaliplatin by Downstream Industry in Germany
4.2.2 Demand Volume of Oxaliplatin by Downstream Industry in United Kingdom
4.2.3 Demand Volume of Oxaliplatin by Downstream Industry in France
4.2.4 Demand Volume of Oxaliplatin by Downstream Industry in Italy
4.2.5 Demand Volume of Oxaliplatin by Downstream Industry in Spain
4.2.6 Demand Volume of Oxaliplatin by Downstream Industry in Benelux
4.2.7 Demand Volume of Oxaliplatin by Downstream Industry in Russia
4.3 Market Forecast of Oxaliplatin in Europe by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF OXALIPLATIN
5.1 Europe Economy Situation and Trend Overview
5.2 Oxaliplatin Downstream Industry Situation and Trend Overview
CHAPTER 6 OXALIPLATIN MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE
6.1 Sales Volume of Oxaliplatin in Europe by Major Players
6.2 Revenue of Oxaliplatin in Europe by Major Players
6.3 Basic Information of Oxaliplatin by Major Players
6.3.1 Headquarters Location and Established Time of Oxaliplatin Major Players
6.3.2 Employees and Revenue Level of Oxaliplatin Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 OXALIPLATIN MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Sanofi-Aventis
7.1.1 Company profile
7.1.2 Representative Oxaliplatin Product
7.1.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Sanofi-Aventis
7.2 Mylan
7.2.1 Company profile
7.2.2 Representative Oxaliplatin Product
7.2.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Mylan
7.3 Sun Pharmaceutical
7.3.1 Company profile
7.3.2 Representative Oxaliplatin Product
7.3.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Sun Pharmaceutical
7.4 Yakult honsha
7.4.1 Company profile
7.4.2 Representative Oxaliplatin Product
7.4.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Yakult honsha
7.5 Hospira
7.5.1 Company profile
7.5.2 Representative Oxaliplatin Product
7.5.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Hospira
7.6 Dr Reddy's laboratories
7.6.1 Company profile
7.6.2 Representative Oxaliplatin Product
7.6.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Dr Reddy's laboratories
7.7 Nanjing Pharmaceutical Factory
7.7.1 Company profile
7.7.2 Representative Oxaliplatin Product
7.7.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Nanjing Pharmaceutical Factory
7.8 Fresenius Kabi
7.8.1 Company profile
7.8.2 Representative Oxaliplatin Product
7.8.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Fresenius Kabi
7.9 Teva
7.9.1 Company profile
7.9.2 Representative Oxaliplatin Product
7.9.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Teva
7.10 Jiangsu Hengrui Medicine
7.10.1 Company profile
7.10.2 Representative Oxaliplatin Product
7.10.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Jiangsu Hengrui Medicine
7.11 Luoxin
7.11.1 Company profile
7.11.2 Representative Oxaliplatin Product
7.11.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Luoxin
7.12 Hainan Jinrui Pharmaceutical
7.12.1 Company profile
7.12.2 Representative Oxaliplatin Product
7.12.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Hainan Jinrui Pharmaceutical
7.13 Jiangsu Aosaikang Pharmaceutical
7.13.1 Company profile
7.13.2 Representative Oxaliplatin Product
7.13.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Jiangsu Aosaikang Pharmaceutical
7.14 Chiatai Tianqing
7.14.1 Company profile
7.14.2 Representative Oxaliplatin Product
7.14.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Chiatai Tianqing
7.15 Halfsky Pharmacy
7.15.1 Company profile
7.15.2 Representative Oxaliplatin Product
7.15.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Halfsky Pharmacy
7.16 Lunan Pharmaceutical
7.17 Qilu Pharmaceutical
7.18 Jari Pharmaceutical
7.19 YRPG
7.20 Hisun Pharmaceutical
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF OXALIPLATIN
8.1 Industry Chain of Oxaliplatin
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF OXALIPLATIN
9.1 Cost Structure Analysis of Oxaliplatin
9.2 Raw Materials Cost Analysis of Oxaliplatin
9.3 Labor Cost Analysis of Oxaliplatin
9.4 Manufacturing Expenses Analysis of Oxaliplatin
CHAPTER 10 MARKETING STATUS ANALYSIS OF OXALIPLATIN
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Oxaliplatin in This Report
1.2 Commercial Types of Oxaliplatin
1.2.1 Mannitol
1.2.2 Glucose Solution
1.2.3 Lactose Solution
1.2.4 Other
1.3 Downstream Application of Oxaliplatin
1.3.1 Colorectal Cancer
1.3.2 Stomach Cancer
1.3.3 Ovarian Cancer
1.3.4 Other
1.4 Development History of Oxaliplatin
1.5 Market Status and Trend of Oxaliplatin 2015-2026
1.5.1 Europe Oxaliplatin Market Status and Trend 2015-2026
1.5.2 Regional Oxaliplatin Market Status and Trend 2015-2026
CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Oxaliplatin in Europe 2015-2019
2.2 Consumption Market of Oxaliplatin in Europe by Regions
2.2.1 Consumption Volume of Oxaliplatin in Europe by Regions
2.2.2 Revenue of Oxaliplatin in Europe by Regions
2.3 Market Analysis of Oxaliplatin in Europe by Regions
2.3.1 Market Analysis of Oxaliplatin in Germany 2015-2019
2.3.2 Market Analysis of Oxaliplatin in United Kingdom 2015-2019
2.3.3 Market Analysis of Oxaliplatin in France 2015-2019
2.3.4 Market Analysis of Oxaliplatin in Italy 2015-2019
2.3.5 Market Analysis of Oxaliplatin in Spain 2015-2019
2.3.6 Market Analysis of Oxaliplatin in Benelux 2015-2019
2.3.7 Market Analysis of Oxaliplatin in Russia 2015-2019
2.4 Market Development Forecast of Oxaliplatin in Europe 2020-2026
2.4.1 Market Development Forecast of Oxaliplatin in Europe 2020-2026
2.4.2 Market Development Forecast of Oxaliplatin by Regions 2020-2026
CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Europe Market Status by Types
3.1.1 Consumption Volume of Oxaliplatin in Europe by Types
3.1.2 Revenue of Oxaliplatin in Europe by Types
3.2 Europe Market Status by Types in Major Countries
3.2.1 Market Status by Types in Germany
3.2.2 Market Status by Types in United Kingdom
3.2.3 Market Status by Types in France
3.2.4 Market Status by Types in Italy
3.2.5 Market Status by Types in Spain
3.2.6 Market Status by Types in Benelux
3.2.7 Market Status by Types in Russia
3.3 Market Forecast of Oxaliplatin in Europe by Types
CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Oxaliplatin in Europe by Downstream Industry
4.2 Demand Volume of Oxaliplatin by Downstream Industry in Major Countries
4.2.1 Demand Volume of Oxaliplatin by Downstream Industry in Germany
4.2.2 Demand Volume of Oxaliplatin by Downstream Industry in United Kingdom
4.2.3 Demand Volume of Oxaliplatin by Downstream Industry in France
4.2.4 Demand Volume of Oxaliplatin by Downstream Industry in Italy
4.2.5 Demand Volume of Oxaliplatin by Downstream Industry in Spain
4.2.6 Demand Volume of Oxaliplatin by Downstream Industry in Benelux
4.2.7 Demand Volume of Oxaliplatin by Downstream Industry in Russia
4.3 Market Forecast of Oxaliplatin in Europe by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF OXALIPLATIN
5.1 Europe Economy Situation and Trend Overview
5.2 Oxaliplatin Downstream Industry Situation and Trend Overview
CHAPTER 6 OXALIPLATIN MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE
6.1 Sales Volume of Oxaliplatin in Europe by Major Players
6.2 Revenue of Oxaliplatin in Europe by Major Players
6.3 Basic Information of Oxaliplatin by Major Players
6.3.1 Headquarters Location and Established Time of Oxaliplatin Major Players
6.3.2 Employees and Revenue Level of Oxaliplatin Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 OXALIPLATIN MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Sanofi-Aventis
7.1.1 Company profile
7.1.2 Representative Oxaliplatin Product
7.1.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Sanofi-Aventis
7.2 Mylan
7.2.1 Company profile
7.2.2 Representative Oxaliplatin Product
7.2.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Mylan
7.3 Sun Pharmaceutical
7.3.1 Company profile
7.3.2 Representative Oxaliplatin Product
7.3.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Sun Pharmaceutical
7.4 Yakult honsha
7.4.1 Company profile
7.4.2 Representative Oxaliplatin Product
7.4.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Yakult honsha
7.5 Hospira
7.5.1 Company profile
7.5.2 Representative Oxaliplatin Product
7.5.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Hospira
7.6 Dr Reddy's laboratories
7.6.1 Company profile
7.6.2 Representative Oxaliplatin Product
7.6.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Dr Reddy's laboratories
7.7 Nanjing Pharmaceutical Factory
7.7.1 Company profile
7.7.2 Representative Oxaliplatin Product
7.7.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Nanjing Pharmaceutical Factory
7.8 Fresenius Kabi
7.8.1 Company profile
7.8.2 Representative Oxaliplatin Product
7.8.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Fresenius Kabi
7.9 Teva
7.9.1 Company profile
7.9.2 Representative Oxaliplatin Product
7.9.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Teva
7.10 Jiangsu Hengrui Medicine
7.10.1 Company profile
7.10.2 Representative Oxaliplatin Product
7.10.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Jiangsu Hengrui Medicine
7.11 Luoxin
7.11.1 Company profile
7.11.2 Representative Oxaliplatin Product
7.11.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Luoxin
7.12 Hainan Jinrui Pharmaceutical
7.12.1 Company profile
7.12.2 Representative Oxaliplatin Product
7.12.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Hainan Jinrui Pharmaceutical
7.13 Jiangsu Aosaikang Pharmaceutical
7.13.1 Company profile
7.13.2 Representative Oxaliplatin Product
7.13.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Jiangsu Aosaikang Pharmaceutical
7.14 Chiatai Tianqing
7.14.1 Company profile
7.14.2 Representative Oxaliplatin Product
7.14.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Chiatai Tianqing
7.15 Halfsky Pharmacy
7.15.1 Company profile
7.15.2 Representative Oxaliplatin Product
7.15.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Halfsky Pharmacy
7.16 Lunan Pharmaceutical
7.17 Qilu Pharmaceutical
7.18 Jari Pharmaceutical
7.19 YRPG
7.20 Hisun Pharmaceutical
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF OXALIPLATIN
8.1 Industry Chain of Oxaliplatin
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF OXALIPLATIN
9.1 Cost Structure Analysis of Oxaliplatin
9.2 Raw Materials Cost Analysis of Oxaliplatin
9.3 Labor Cost Analysis of Oxaliplatin
9.4 Manufacturing Expenses Analysis of Oxaliplatin
CHAPTER 10 MARKETING STATUS ANALYSIS OF OXALIPLATIN
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
